Table 2 Olink protein panels.

From: Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

Immuno-oncology panel

Oncology panel II

ADA

CASP-8

IL-18

5′-NT

ADAM8

IFN-γ-R1

ADGRG1

FASL

IL-2

ADAM-TS 15

ESM-1

IL6

ANGPT1

FGF2

IL-33

TXLNA

EPHA2

HK11

TIE2

CX3CL1

IL-4

AREG

FASL

KLK13

ANGPT2

GAL-1

IL5

ANXA1

FADD

HK14

ARG1

GAL-9

IL6

CD207

FCRLB

HK8

CCL17

GZMA

IL-7

CXCL13

FGF-BP1

LYPD3

CCL19

GZMB

IL-8

CAIX

FR-ALPHA

MIA

CCL20

GZMH

KIR3DL1

CPE

FR-GAMMA

MSLN

CCL23

HO-1

LAP TGFB1

CEA

FUR

METAP2

CCL3

HGF

LAG3

CEACAM1

GAL-1

MIC-A/B

CCL4

ICOSLG

LAMP3

CTSV

GPC1

MK

CXCL1

IFN-GAMMA

CSF-1

CD160

GZMB

MAD H5

CXCL10

IL-1 ALPHA

MMP-12

CD27

GZMH

MUC-16

CXCL11

IL10

MMP-7

CD48

HGF

PVRL4

CXCL13

IL-12

MIC-A/B

CD70

ICOSLG

PPY

CXCL5

IL12RB1

MCP-1

CRNN

IGF1R

PODXL

CXCL9

IL-13

MCP-2

CDKN1A

ITGAV

EGF

CAIX

IL15

PTN

DLL1

ITGB5

SCAMP3

MCP-3

CD40-L

EGF

CYR61

TLR3

SEZ6L

MCP-4

CD28

PD-L1

S100A11

TGF-ALPHA

 

MUC-16

TRAIL

PD-L2

S100A4

GPNMB

SPARC

NCR1

TWEAK

PDCD1

RET

TNFSF13

SCF

CD244

TNF

CXCL12

RSPO3

TNFRSF19

SYND1

KLRD1

TNFSF14

CD4

HER2

TNFRSF4

TCL1A

NOS3

TNFRSF12A

CD5

HER3

TNFRSF6B

LY9

PGF

TNFRSF21

CD8A

HER4

ABL1

TGFR-2

PDGF-B

TNFRSF4

CRTAM

WFDC2

LYN

TFPI-2

CD40

TNFRSF9

DCN

WIF-1

VEGF-A

TRAIL

CD70

VEGF-A

CD27

WISP-1

VEGFR-2

CXCL17

CD83

VEGFR-2

 

XPNPEP2

VEGFR-3

VIM